Arrowstreet Capital, Limited Partnership Teva Pharmaceutical Industries LTD Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 14,897,625 shares of TEVA stock, worth $254 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

14,897,625

Previous 5,802,519 156.74%

Holding current value

$254 Million

Previous $94.3 Million 184.71%

% of portfolio

0.22%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $144 Million - $172 Million	9,095,106 Added 156.74%	14,897,625 $268 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $58.4 Million - $79.5 Million	4,570,086 Added 370.82%	5,802,519 $94.3 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $29.6 Million - $40 Million	-2,770,223 Reduced 69.21%	1,232,433 $17.4 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $460,452 - $602,784	56,706 Added 1.44%	4,002,656 $41.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $29.5 Million - $42.2 Million	3,945,950 New	3,945,950 $40.2 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $13.1 Million - $15.7 Million	-1,651,666 Reduced 97.84%	36,489 $333,000
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $5.51 Million - $9.61 Million	-803,788 Reduced 32.26%	1,688,155 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3.42 Million - $4.82 Million	463,456 Added 22.85%	2,491,943 $18.7 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $13.5 Million - $17.2 Million	1,835,952 Added 953.57%	2,028,487 $19 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $1.52 Million - $1.96 Million	192,535 New	192,535 $1.54 Million
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $8.63 Million - $10.7 Million	-834,320 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $22.1 Million - $28.3 Million	-2,565,487 Reduced 75.46%	834,320 $8.05 Million
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $12.7 Million - $18.8 Million	-1,478,630 Reduced 30.31%	3,399,807 $30.6 Million
Q2 2020 Aug 12, 2020	BUY	$8.12 - $13.12 $18 Million - $29.1 Million	2,218,983 Added 83.44%	4,878,437 $60.2 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $17.8 Million - $35.8 Million	2,659,454 New	2,659,454 $23.9 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $4.85 Million - $7.57 Million	-788,086 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $6.4 Million - $12.4 Million	788,086 New	788,086 $7.27 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $37.7 Million - $48.4 Million	-2,421,092 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $27.3 Million - $44.6 Million	1,869,786 Added 339.16%	2,421,092 $37.3 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $11.6 Million - $14.1 Million	551,306 New	551,306 $11.9 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Teva Pharmaceutical Industries LTD Transaction History